2276 Development of the expanded access oversight committee at Michigan Medicine

por Weatherwax, Kevin, Hutchinson, Ray, Mashour, George, Gravelin, Misty
Publicado 2018

400 Exploring the Diversity of Expanded Access Patients at Michigan Medicine

por Gravelin, Misty, Frank, Chelsea, Rigan, Laurie, Wright, Jeanne, Weatherwax, Kevin
Publicado 2023

Adapting an Expanded Access program to enable investigational treatments for COVID-19

por Samuels, Elias, Champagne, Ellen, Gravelin, Misty, Racklyeft, Jamie, Weatherwax, Kevin
Publicado 2022

Right now, in the right way: U. S. Food and Drug Administration’s expanded access program and patient rights

por Holbein, M. E. Blair, Weatherwax, Kevin J., Gravelin, Misty, Hutchinson, Raymond, Mashour, George A.
Publicado 2018

Real-World Data Collection from Expanded Access Case Studies for the Treatment of Nontuberculous Mycobacterial Infection with Clofazimine

por Gravelin, Misty, Nguyen, Theophilus, Davies, Madeleine, Richards, Blair, Sexton, Jonathan Z., Gregg, Kevin, Weatherwax, Kevin J.
Publicado 2023

2543: Participatory development of a CTSA-wide Community Advisory Board: Enhancing community engagement at the Michigan Institute for Clinical & Health Research

por Delva, Jorge, Paberzs, Adam, Piechowski, Patricia, Calhoun, Karen, Carr, Diane, Spiroff, Meghan, Buyuktur, Ayse, Weatherwax, Kevin
Publicado 2018

Pacemaker recycling: A notion whose time has come

por Runge, Mason W, Baman, Timir S, Davis, Sheldon, Weatherwax, Kevin, Goldman, Ed, Eagle, Kim A, Crawford, Thomas C
Publicado 2017

Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic

por Gravelin, Misty, Wright, Jeanne, Holbein, M.E. Blair, Berro, Marlene, Brown, Jennifer S., Mashour, George A., Weatherwax, Kevin J.
Publicado 2021

National landscape assessment of academic medical center support for expanded access to investigational products

por Gravelin, Misty, Adamo, Joan E., Ellison, Sharon, Segear, Erika, Parrish, Amanda B., Deeter, Christine, Hamill, Jennifer, Rigan, Laurie, Mashour, George A., Weatherwax, Kevin J.
Publicado 2022

Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19

por Mirabelli, Carmen, Wotring, Jesse W., Zhang, Charles J., McCarty, Sean M., Fursmidt, Reid, Frum, Tristan, Kadambi, Namrata S., Amin, Anya T., O’Meara, Teresa R., Pretto, Carla D., Spence, Jason R., Huang, Jessie, Alysandratos, Konstantinos D., Kotton, Darrell N., Handelman, Samuel K., Wobus, Christiane E., Weatherwax, Kevin J., Mashour, George A., O’Meara, Matthew J., Sexton, Jonathan Z.
Publicado 2020

Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19

por Mirabelli, Carmen, Wotring, Jesse W., Zhang, Charles J., McCarty, Sean M., Fursmidt, Reid, Pretto, Carla D., Qiao, Yuanyuan, Zhang, Yuping, Frum, Tristan, Kadambi, Namrata S., Amin, Anya T., O’Meara, Teresa R., Spence, Jason R., Huang, Jessie, Alysandratos, Konstantinos D., Kotton, Darrell N., Handelman, Samuel K., Wobus, Christiane E., Weatherwax, Kevin J., Mashour, George A., O’Meara, Matthew J., Chinnaiyan, Arul M., Sexton, Jonathan Z.
Publicado 2021